Cleared Traditional

“POINT” Kinguide Agile Hybrid Navigation System (PSHF01-000) (K241130) - FDA 510(k) Clearance

Class II Orthopedic device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K241130 · Point Robotics MedTech, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2024
Decision
91d
Days
Class 2
Risk

K241130 is an FDA 510(k) clearance for the “POINT” Kinguide Agile Hybrid Navigation System (PSHF01-000). Classified as Orthopedic Stereotaxic Instrument within the OLO classification (a category covering orthopedic stereotaxic and surgical navigation instruments), Class II - Special Controls.

Submitted by Point Robotics MedTech, Inc. (New Taipei City, TW). The FDA issued a Cleared decision on July 24, 2024 after a review of 91 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 882.4560 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Point Robotics MedTech, Inc. devices

Submission Details

510(k) Number K241130 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 24, 2024
Decision Date July 24, 2024
Days to Decision 91 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
31d faster than avg
Panel avg: 122d · This submission: 91d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OLO Orthopedic Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
Definition Stereotaxic Guidance During Orthopedic Surgery Procedures. Indicated For Orthopedic Joint Or Spine Surgery. Neurological Stereotaxic Instruments Are Classified Under Product Code Haw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - OLO Orthopedic Stereotaxic Instrument

All 344
Devices cleared under the same product code (OLO) and FDA review panel - the closest regulatory comparables to K241130.
Bendini Cloud Application
K233706 · Nuvasive · Aug 2024
Spine Navigation System
K233725 · Medivis, Inc. · Jul 2024
Spine Guidance Software (Version 5.1)
K241171 · Stryker Leibinger GmbH & Co KG · Jul 2024
TMINI Miniature Robotic System (TMINI 1.1)
K241031 · THINK Surgical, Inc. · Jul 2024
Anatase Navi Disposable Instrument
K241625 · Remex Medical Corp. · Jul 2024
CROSSNAV Navigation Enabled Instruments
K233255 · DePuy Synthes · Jun 2024